We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Neutrophil‐Lymphocyte Ratio and Lactate Predict Mortality in Septic Patients

By LabMedica International staff writers
Posted on 23 Jul 2019
Sepsis is the primary cause of death from infection. More...
It is also one of the leading causes of intensive care unit (ICU) mortality, despite early administration of antibiotics and hemodynamic management.

Plasma biomarkers may have diagnostic, prognostic, and theranostic values, all of which are important factors influencing outcomes in patients with sepsis. White blood cell (WBC) enumeration has been identified as an important systemic inflammation marker. The neutrophil‐to‐lymphocyte ratio (NLR) is a rapid and simple parameter of systemic inflammation and stress.

Scientists at the Changai Hospital (Shanghai, China) and their colleagues conducted a prospective, observational study that included 63 nonsurgical and non-trauma adult patients with sepsis admitted to the Department of Critical Care Medicine from September 2016 to October 2018. Baseline characteristics of the patients including demographics (age and gender), comorbidities (cardiovascular disease, chronic lung disease, and diabetes, among others), and primary diagnosis were recorded. In addition, healthy subjects were assigned to a control group.

The team collected blood samples within 24 hours after diagnosis. Routine blood tests, blood gas analysis, and procalcitonin (PCT) concentrations were conducted in the hospital's central laboratory. Routine blood tests, including neutrophil count and lymphocyte count performed on a blood analyzer, XN9000, C-reactive protein (CRP) estimated by scattering nephelometry, and plasma PCT concentrations were measured using a time‐resolved amplified cryptate emission technology assay. Plasma lactate was evaluated on an ABL800 Flex.

The scientists reported that NLR and plasma lactate levels of the patients were significantly higher than those of control subjects: 19.44 (14.3‐34.53) versus 14.09 (8.17‐28.99), and 3.7 (3‐6.6) versus 2.72 (2.13‐4.3) ng/mL, respectively. There were no statistical differences in the concentrations of PCT and CRP between non-survivors and survivors. With an optimal cutoff of 14.08, the sensitivity and specificity of NLR for prediction of 28‐day mortality were 78.3% and 50%, respectively. The sensitivity and specificity of plasma lactate level to predict 28‐day mortality, at an optimal cutoff value of 2.99 mmol/L, were 82.6% and 55%, respectively.

The authors concluded that elevated NLR and lactate levels showed significant association with increased mortality in patients with sepsis. NLR and lactate may be important prognostic biomarkers to optimize treatment and manage patients. The study was published on July 2, 2019, in the Journal of Clinical Laboratory Analysis.

Related Links:
Changai Hospital


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.